Efficacy and Safety of Tamibarotene (OAM80) for Alzheimer's Disease

Summary

A double blind, placebo-controlled randomized study to evaluate the efficacy and safety of orally administered Tamibarotene to patients of Alzheimer's Disease

Timeline

Start

2010-05

Primary completion

2012-12

Completion

2012-12

Publications

• Background Shudo K, Fukasawa H, Nakagomi M, Yamagata N. Towards retinoid therapy for Alzheimer's disease. Curr Alzheimer Res. 2009 Jun;6(3):302-11. doi: 10.2174/156720509788486581.

Drugs

Indications